IPCI Short Information, Intellipharmaceutics International Inc.

Twenty Trading Day Totals
Total Shorted Volume	2,032,913
Total Actual Volume	20,086,626

Averages
Average Short Volume	101,646
Average Short Percentage	33.46%

Is there a IPCI Short Squeeze or Breakout about to happen?

See the IPCI Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2019-03-20	0.22	0.2106	0.267	0.21	2,279,585	90,443	12.9838
2019-03-19	0.275	0.27	0.2786	0.2619	127,424	18,413	41.7103
2019-03-18	0.27	0.275	0.2822	0.25	343,757	58,689	47.8551
2019-03-15	0.25	0.2531	0.27	0.25	332,663	82,250	60.8012
2019-03-14	0.2525	0.263	0.2755	0.245	204,353	12,186	21.9216
2019-03-13	0.23	0.254	0.265	0.23	385,400	31,072	27.2952
2019-03-12	0.2774	0.2448	0.2774	0.2404	201,082	15,444	17.3232
2019-03-11	0.248	0.24	0.249	0.24	105,582	6,202	22.1627
2019-03-08	0.233	0.2422	0.2488	0.2203	544,714	66,464	27.2958
2019-03-07	0.26	0.245	0.2682	0.21	810,812	120,049	50.7105
2019-03-06	0.2699	0.2505	0.27	0.25	594,899	62,063	30.7434
2019-03-05	0.29	0.2735	0.29	0.2668	556,611	37,253	28.0020
2019-03-04	0.3199	0.29	0.3445	0.2803	1,800,992	212,978	39.9313
2019-03-01	0.2999	0.2751	0.30	0.26	1,942,164	97,219	16.3604
2019-02-28	0.321	0.3119	0.33	0.3105	693,438	71,580	28.7353
2019-02-27	0.3352	0.3245	0.3416	0.3201	683,090	66,254	33.7560
2019-02-26	0.3499	0.3401	0.3582	0.31	3,055,414	409,471	42.4926
2019-02-25	0.357	0.3435	0.3699	0.34	1,116,195	73,029	26.5429
2019-02-22	0.39	0.38	0.39	0.3601	1,423,679	110,559	38.6539
2019-02-21	0.3799	0.3867	0.40	0.344253	2,884,772	391,295	53.8946

Stock Information

Intellipharmaceutics International Inc. Company Name:

IPCI Stock Symbol:

NASDAQ Market:

IPCI Short Information, Intellipharmaceutics International Inc.

Get IPCI Alerts

News, Short Squeeze, Breakout and More Instantly...

IPCI - Intellipharmaceutics Receives Nasdaq Listing Determination; To Begin Trading on the OTC Markets System

TORONTO, ON / ACCESSWIRE / March 19, 2019 / Intellipharmaceutics International Inc. (Nasdaq and TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
IPCI - Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER

TORONTO, ON / ACCESSWIRE / March 4, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rele...
IPCI - Intellipharmaceutics Announces Fiscal Year 2018 Results

TORONTO, ON / ACCESSWIRE / February 22, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targe...